RezaRazeghinejadMD

Cataract Related, Glaucoma Related

Associate Professor, Director of Glaucoma fellowship

Dr. Razeghinejad is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

Office
840 Walnut St
Ste 1110
Philadelphia, PA 19107
Phone+1 215-928-3197

Fax+1 215-928-0166

PubMed

Latanoprostene bunod: the first nitric oxide-donating antiglaucoma medication.
Ghazaleh Soltani, Wesam Shamseldin Shalaby, Reza Razeghinejad
Medical Gas Research. 2025-06-01
Establishing normal interocular symmetry range for macular optical coherence tomography parameters in healthy children.
Athar Zareei, Reza Razeghinejad, Mohammad Reza Talebnejad, Mohammad Reza Khalili, Masoumeh Sadat Masoumpour
Eye. 2025-01-10
GLP-1 Receptor Agonists Use and Incidence of Glaucoma: A Systematic Review and Meta-Analysis.
Dillan Cunha Amaral, Jaime Guedes, Matheus Ribeiro Barbosa Cruz, Lídia Cheidde, Matheus Nepomuceno
American Journal of Ophthalmology. 2024-12-27